We also developed an immune assay to assess the effects of patient plasma on healthy monocyte-derived macrophage tumor necrosis factor (TNF) production because monocyte deactivation is a key feature of AD/ACLF and reduced monocyte TNF production predicts poor outcomes in sepsis.11 This evidence concerns the gene TNF and Alzheimer disease.